The first stop for professional medicines advice

Medicine

313 results

Applied filters

Preparing to use aflibercept 2mg biosimilar

4 July 2025Aflibercept 2mg biosimilars for use in ophthalmology are expected in December 2025 for NHS use. We offer general information and implementation advice.

Oral benzodiazepines and choosing equivalent doses

2 July 2025Equivalent doses of oral benzodiazepines to diazepam are not exact. Consider these factors before switching.

Choosing between oral vancomycin options

18 June 2025Organisations should choose suitable formulary options for oral vancomycin and mitigate risks. Several factors affect decision making.

Choosing between fidaxomicin options

18 June 2025Organisations should choose suitable fidaxomicin formulary options and mitigate risks. Several factors affect decision making.

Preventing harm from incorrect vinca alkaloid administration

13 June 2025Vinca alkaloids can cause paralysis and death if given by the wrong route. Understand how to reduce the risk to patients.

Doxycycline post exposure prophylaxis (doxyPEP)

11 June 2025SPS PGD template for supply of doxycycline post exposure prophylaxis (doxyPEP) for the prevention of syphilis.

Implementing pharmacogenomic testing for aminoglycosides

10 June 2025Patients with mitochondrial variants have an increased risk of deafness with amikacin, gentamicin, neomycin and tobramycin. Guidance on testing is provided.

Choosing a prokinetic medicine for impaired gastrointestinal motility

23 May 2025Prokinetics improve gastrointestinal motility. We advise on suitable prokinetic options, including dose and safety considerations.

Preparing to use golimumab biosimilar

21 May 2025Golimumab biosimilars are expected soon. We offer general information and implementation advice.

Ziconotide: informing intrathecal risk assessment

16 May 2025Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration